WO2001029269A3 - Gene expression profiling of inflammatory bowel disease - Google Patents
Gene expression profiling of inflammatory bowel disease Download PDFInfo
- Publication number
- WO2001029269A3 WO2001029269A3 PCT/US2000/041457 US0041457W WO0129269A3 WO 2001029269 A3 WO2001029269 A3 WO 2001029269A3 US 0041457 W US0041457 W US 0041457W WO 0129269 A3 WO0129269 A3 WO 0129269A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inflammatory bowel
- ibd
- gene expression
- cells
- expression profiling
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00988479A EP1287162A2 (en) | 1999-10-21 | 2000-10-23 | Gene expression profiling of inflammatory bowel disease |
IL14393600A IL143936A0 (en) | 1999-10-21 | 2000-10-23 | Gene expression profiling of inflammatory bowel disease |
CA2356207A CA2356207C (en) | 1999-10-21 | 2000-10-23 | Gene expression profiling of inflammatory bowel disease |
AU24685/01A AU784861B2 (en) | 1999-10-21 | 2000-10-23 | Gene expression profiling of inflammatory bowel disease |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16083599P | 1999-10-21 | 1999-10-21 | |
US60/160,835 | 1999-10-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001029269A2 WO2001029269A2 (en) | 2001-04-26 |
WO2001029269A3 true WO2001029269A3 (en) | 2002-12-05 |
Family
ID=22578660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/041457 WO2001029269A2 (en) | 1999-10-21 | 2000-10-23 | Gene expression profiling of inflammatory bowel disease |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP1287162A2 (en) |
AU (1) | AU784861B2 (en) |
CA (1) | CA2356207C (en) |
IL (1) | IL143936A0 (en) |
WO (1) | WO2001029269A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8877192B2 (en) | 2004-08-03 | 2014-11-04 | Transtech Pharma, Llc | Rage fusion proteins and methods of use |
US9034341B2 (en) | 2009-04-20 | 2015-05-19 | Transtech Pharma, Llc | Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6525018B1 (en) | 1999-05-17 | 2003-02-25 | The General Hospital Corp. | Treating eye disorders using intestinal trefoil proteins |
US6960439B2 (en) | 1999-06-28 | 2005-11-01 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
US7538082B2 (en) | 2001-04-24 | 2009-05-26 | The General Hospital Corporation | Methods and compositions for treating oral and esophageal lesions |
US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
CA2842429A1 (en) * | 2001-10-19 | 2003-05-01 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
JP5236856B2 (en) | 2001-11-09 | 2013-07-17 | ライフ テクノロジーズ コーポレーション | Identification, observation and treatment of diseases and identification of biological states using gene expression profiles |
JP4437193B2 (en) * | 2002-03-29 | 2010-03-24 | 独立行政法人産業技術総合研究所 | Nucleic acid library and protein library |
AU2003247303A1 (en) * | 2002-07-17 | 2004-02-02 | Index Pharmaceuticals Ab | Antisense compounds, methods and compositions for treating ngal-related inflammatory disorders |
JP2006500073A (en) * | 2002-07-18 | 2006-01-05 | インデックス・ファーマシューティカルズ・アクチエボラーグ | Antisense compounds, methods and compositions for treating MMP-12 related inflammatory disorders |
DE10328813B4 (en) * | 2003-06-20 | 2006-04-13 | Epigenomics Ag | Method for the investigation of cytosine methylations in DNA sequences using triplex-forming oligomers |
ES2326708B1 (en) * | 2005-10-05 | 2010-09-30 | Progenika Biopharma, S.A. | METHODS AND PRODUCTS FOR GENOTIPADO IN VITRO. |
CA2594730A1 (en) * | 2005-01-13 | 2006-07-20 | Progenika Biopharma, S.A. | Methods and products for in vitro genotyping |
US8153363B2 (en) | 2005-01-13 | 2012-04-10 | Progenika Biopharma S.A. | Methods and products for in vitro genotyping |
WO2006133287A2 (en) * | 2005-06-06 | 2006-12-14 | Wyeth | Expression profiles of peripheral blood mononuclear cells for inflammatory bowel diseases |
EP2380983A3 (en) | 2006-05-05 | 2012-12-05 | TransTech Pharma Inc. | RAGE fusion proteins, formulations, and methods of use thereof |
US20100267575A1 (en) * | 2006-10-17 | 2010-10-21 | Childrens Hospital Medical Center | Gene array technique for predicting response in inflammatory bowel diseases |
WO2008147869A2 (en) | 2007-05-22 | 2008-12-04 | Centocor, Inc. | Markers and methods for assessing and treating crohn's disease and related disorders |
RU2513695C2 (en) | 2007-06-14 | 2014-04-20 | Гэлэктика Фармасьютикалс, Инк. | Fused rage proteins |
MX2010005893A (en) * | 2007-11-29 | 2011-03-04 | Genentech Inc Star | Gene expression markers for inflammatory bowel disease. |
US7833720B2 (en) | 2008-03-14 | 2010-11-16 | Exagen Diagnostics, Inc. | Biomarkers for inflammatory bowel disease and irritable bowel syndrome |
ES2356458B1 (en) * | 2009-09-11 | 2012-01-23 | Progenika Biopharma, S.A. | METHODS AND PRODUCTS FOR IN VITRO GENOTIPATE OF HUMAN GENETIC VARIATIONS ASSOCIATED WITH REACTIONS ADVERSE TO DRUGS. |
WO2014205507A1 (en) * | 2013-06-28 | 2014-12-31 | Newsouth Innovations Pty Limited | Diagnostic method |
WO2019008093A1 (en) * | 2017-07-07 | 2019-01-10 | University Of Copenhagen | Markers for diagnosing inflammatory bowel diseases |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000014283A2 (en) * | 1998-09-04 | 2000-03-16 | Washington University | Gene markers for chronic mucosal injury |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4902505A (en) | 1986-07-30 | 1990-02-20 | Alkermes | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
CA1319101C (en) | 1986-09-03 | 1993-06-15 | Marta Iris Sabara | Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules |
US5116742A (en) | 1986-12-03 | 1992-05-26 | University Patents, Inc. | RNA ribozyme restriction endoribonucleases and methods |
US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
US4904582A (en) | 1987-06-11 | 1990-02-27 | Synthetic Genetics | Novel amphiphilic nucleic acid conjugates |
US5254678A (en) | 1987-12-15 | 1993-10-19 | Gene Shears Pty. Limited | Ribozymes |
US5176996A (en) | 1988-12-20 | 1993-01-05 | Baylor College Of Medicine | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
US5256775A (en) | 1989-06-05 | 1993-10-26 | Gilead Sciences, Inc. | Exonuclease-resistant oligonucleotides |
US5144019A (en) | 1989-06-21 | 1992-09-01 | City Of Hope | Ribozyme cleavage of HIV-I RNA |
US5225337A (en) | 1989-09-25 | 1993-07-06 | Innovir Laboratories, Inc. | Ribozyme compositions and methods for use |
US5264564A (en) | 1989-10-24 | 1993-11-23 | Gilead Sciences | Oligonucleotide analogs with novel linkages |
US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
US5498531A (en) | 1993-09-10 | 1996-03-12 | President And Fellows Of Harvard College | Intron-mediated recombinant techniques and reagents |
US5631734A (en) | 1994-02-10 | 1997-05-20 | Affymetrix, Inc. | Method and apparatus for detection of fluorescently labeled materials |
US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
US6974666B1 (en) | 1994-10-21 | 2005-12-13 | Appymetric, Inc. | Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA |
WO1997027317A1 (en) | 1996-01-23 | 1997-07-31 | Affymetrix, Inc. | Nucleic acid analysis techniques |
US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
AU700952B2 (en) | 1995-06-07 | 1999-01-14 | Pioneer Hi-Bred International, Inc. | PCR-based cDNA subtractive cloning method |
US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
US5654173A (en) | 1996-08-23 | 1997-08-05 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
AU707636C (en) | 1995-11-23 | 2003-01-16 | Cancer Research Campaign Technology Limited | Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof |
AU2189397A (en) | 1996-02-08 | 1997-08-28 | Affymetrix, Inc. | Chip-based speciation and phenotypic characterization of microorganisms |
US6458530B1 (en) | 1996-04-04 | 2002-10-01 | Affymetrix Inc. | Selecting tag nucleic acids |
-
2000
- 2000-10-23 EP EP00988479A patent/EP1287162A2/en not_active Withdrawn
- 2000-10-23 EP EP10182252A patent/EP2319939A3/en not_active Withdrawn
- 2000-10-23 IL IL14393600A patent/IL143936A0/en unknown
- 2000-10-23 WO PCT/US2000/041457 patent/WO2001029269A2/en active Application Filing
- 2000-10-23 CA CA2356207A patent/CA2356207C/en not_active Expired - Lifetime
- 2000-10-23 AU AU24685/01A patent/AU784861B2/en not_active Expired
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000014283A2 (en) * | 1998-09-04 | 2000-03-16 | Washington University | Gene markers for chronic mucosal injury |
Non-Patent Citations (12)
Title |
---|
ALEXANDER RICHARD J ET AL: "Expression of protooncogene-encoded mRNA by colonic epithelial cells in inflammatory bowel disease.", DIGESTIVE DISEASES AND SCIENCES, vol. 41, no. 4, 1996, pages 660 - 669, XP001064180, ISSN: 0163-2116 * |
CAMACHO F I ET AL: "CD44v6 expression in inflammatory bowel disease is associated with activity detected by endoscopy and pathological features.", HISTOPATHOLOGY (OXFORD), vol. 35, no. 2, August 1999 (1999-08-01), pages 144 - 149, XP002207657, ISSN: 0309-0167 * |
DIECKGRAEFE B ET AL: "Characterization of mucosal gene expression in inflammatory bowel disease by direct hybridization to massively parallel oligonucleotide arrays", DIGESTIVE DISEASES AND SCIENCES, PLENUM PUBLISHING CO, US, vol. 114, no. 4, PART 2, 1998, pages ABSTG3954, XP000877256, ISSN: 0163-2116 * |
DIECKGRAEFE B K ET AL: "Expression of the regenerating gene family in inflammatory bowel disease: potential role as an injury-induced tissue mitogen", GASTROENTEROLOGY, SAUNDERS, PHILADELPHIA, PA,, US, vol. 116, no. 4, PART 2, April 1999 (1999-04-01), pages A601, XP000876959, ISSN: 0016-5085 * |
FUNAKOSHI K ET AL: "Spectrum of cytokine gene expression in intestinal mucosal lesions of Crohn's disease and ulcerative colitis.", DIGESTION, vol. 59, no. 1, January 1998 (1998-01-01), pages 73 - 78, XP001064174, ISSN: 0012-2823 * |
GOLUB T R ET AL: "Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring.", SCIENCE (WASHINGTON D C), vol. 286, no. 5439, 15 October 1999 (1999-10-15), pages 531 - 537, XP002207658, ISSN: 0036-8075 * |
HOSOKAWA TAKEHIKO ET AL: "Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease.", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 14, no. 10, October 1999 (1999-10-01), pages 987 - 996, XP001064163, ISSN: 0815-9319 * |
MAZZUCCHELLI LUCA ET AL: "Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease.", JOURNAL OF PATHOLOGY, vol. 178, no. 2, 1996, pages 201 - 206, XP001064186, ISSN: 0022-3417 * |
PALLONE F ET AL: "Hla-d region antigens on isolated human colonic epithelial cells enhanced expression in inflammatory bowel disease and in-vitro induction by different stimuli", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, vol. 74, no. 1, 1988, pages 75 - 79, XP001064184, ISSN: 0009-9104 * |
SATSANGI J ET AL: "GENETIC MARKERS IN INFLAMMATORY BOWEL DISEASE", CURRENT OPINION IN GASTROENTEROLOGY, GOWER ACADEMIC JOURNALS, LONDON, GB, vol. 12, no. 4, 1 July 1996 (1996-07-01), pages 322 - 326, XP000619908, ISSN: 0267-1379 * |
WILD G E ET AL: "ANALYSIS OF GENE EXPRESSION IN INFLAMMATORY BOWEL DISEASE BY DIFFERENTIAL DISPLAY PCR OF COLONOCYTE MRNA", GASTROENTEROLOGY, SAUNDERS, PHILADELPHIA, PA,, US, vol. 112, no. 4, SUPPL, 1997, pages A1118, XP000877180, ISSN: 0016-5085 * |
ZUO LI ET AL: "mRNA differential display of colonic mucosa cells in ulcerative colitis.", JOURNAL OF SURGICAL RESEARCH, vol. 69, no. 1, 1997, pages 119 - 127, XP000877187, ISSN: 0022-4804 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8877192B2 (en) | 2004-08-03 | 2014-11-04 | Transtech Pharma, Llc | Rage fusion proteins and methods of use |
US9034341B2 (en) | 2009-04-20 | 2015-05-19 | Transtech Pharma, Llc | Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions |
Also Published As
Publication number | Publication date |
---|---|
EP1287162A2 (en) | 2003-03-05 |
IL143936A0 (en) | 2002-04-21 |
CA2356207C (en) | 2012-10-09 |
AU2468501A (en) | 2001-04-30 |
CA2356207A1 (en) | 2001-04-26 |
WO2001029269A2 (en) | 2001-04-26 |
AU784861B2 (en) | 2006-07-06 |
EP2319939A3 (en) | 2012-09-26 |
EP2319939A2 (en) | 2011-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001029269A3 (en) | Gene expression profiling of inflammatory bowel disease | |
Goodrich et al. | The relationship between the human genome and microbiome comes into view | |
Langefeld et al. | Transancestral mapping and genetic load in systemic lupus erythematosus | |
Castillo-Fernandez et al. | Epigenetics of discordant monozygotic twins: implications for disease | |
Gibbons | Alpha thalassaemia-mental retardation, X linked | |
Zoetendal et al. | Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces | |
Gertz et al. | Analysis of DNA methylation in a three-generation family reveals widespread genetic influence on epigenetic regulation | |
Cavailles et al. | A highly conserved Toxo1 haplotype directs resistance to toxoplasmosis and its associated caspase-1 dependent killing of parasite and host macrophage | |
CN104561016B (en) | New mutation of congenital cataract PITX3 gene | |
WO2005024603A3 (en) | Methods for detecting, diagnosing and treating human renal cell carcinoma | |
Logue et al. | The ankyrin-3 gene is associated with posttraumatic stress disorder and externalizing comorbidity | |
Ji et al. | Association of host genetics with intestinal microbial relevant to body weight in a chicken F2 resource population | |
Hempelmann et al. | Exploration of the genetic architecture of idiopathic generalized epilepsies | |
Kellermayer | Challenges for epigenetic research in inflammatory bowel diseases | |
Winkler et al. | Fuchs' endothelial corneal dystrophy in patients with myotonic dystrophy, type 1 | |
del Carmen Plaza-Serón et al. | Copy number variation in ALOX5 and PTGER1 is associated with NSAIDs-induced urticaria and/or angioedema | |
Zhao et al. | The effects of gene duplication modes on the evolution of regulatory divergence in wild and cultivated soybean | |
CN104745592A (en) | CYP4V2 gene mutant and application thereof | |
CN104073499B (en) | TMC1 gene mutation body and its application | |
Wang et al. | Comparison of different normalization assumptions for analyses of DNA methylation data from the cancer genome | |
Lewitus et al. | Neocortical development as an evolutionary platform for intragenomic conflict | |
CN104745594A (en) | CYP4V2 gene mutant and application thereof | |
Kwabi-Addo | Health Outcomes in a Foreign Land | |
Adam et al. | Hepatocarcinogenesis in non‐cirrhotic liver is associated with a reduced number of clonal hepatocellular patches in non‐tumorous liver parenchyma | |
Ma et al. | Use of high-throughput targeted exome sequencing in genetic diagnosis of Chinese family with congenital cataract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA IL JP NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2356207 Country of ref document: CA Kind code of ref document: A Ref document number: 2356207 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 143936 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 513088 Country of ref document: NZ Ref document number: 24685/01 Country of ref document: AU Ref document number: 2000988479 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA IL JP NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWP | Wipo information: published in national office |
Ref document number: 2000988479 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |